Select Page
Select Page

Special Interest Groups

A Special Interest Group (SIG) is a group of ISoP members acting as volunteers and working on a specific and relevant topic which is within the scope and aims of ISoP.

Currently there are established SIGs on

‘Women’s medicines’,
‘Risk communication’,
‘Risk Minimisation Methods for Asian countries’,
‘Herbal and Traditional Medicines’,
‘PV Professional Qualification Framework’,
‘Medication Errors’,
‘Vaccine surveillance’
‘Pharmacogenomics’
‘Medical Device Safety’,
‘Patient Engagement’
‘Ecopharmacovigilance’
‘Drug Safety in Older Patients’.

To explore our Special Interest Groups, please use the green navigation menu.

Guidelines:

Please click the button to the right for the latest SIG guidelines – or contact ISoP Administration for more information.

ISoP SIG

Women’s Medicine Group

Women, half of our worldwide population, take medicines throughout their lifetime. This SIG focusses on the proper use of medicines, their benefits and harms.

READ MORE

Risk Communication Group

This SIG deals with all aspects of risk communication as a sub-discipline of safety surveillance and risk mitigation of medicines.

READ MORE
ISoP SIG
ISoP SIG

Risk Minimisation Methods for Asian countries

The focus of this SIG will be to elaborate and deliver risk minimization methods and strategies able to fit particularly the needs of countries in Asia.

READ MORE

Herbal and Traditional Medicines Group

Exploring issues relating to the safety and Pharmacovigilance of herbal and traditional medicines.

READ MORE
ISoP SIG
ISoP SIG

Pharmacovigilance Professional Qualification Framework Group

Responding to the need of harmonisation in professional pharmacovigilance qualifications.

READ MORE

Medication Errors

Ensuring the safe and effective use healthcare products is a key objective for all who work in pharmacovigilance, patients and all other stakeholders.

READ MORE
ISoP SIG
ISoP SIG

Vaccine Surveillance

Recent years have brought new challenges to the field of vaccine safety surveillance.

READ MORE

Pharmacogenomics

There is large interindividual variability in drug response. Some of the variation is related to inherited characteristics of the genome. These genomic variations may relate to pharmacokinetics (PK) or pharmacodynamics (PD) or to individual’s susceptibility.

READ MORE
ISoP SIG
ISoP SIG

Medical Devices

We have created the Medical Device Safety Special Interest Group to provide a forum for members to share experiences to suggest and discuss best practices and policy in the field of medical device performance monitoring and safety surveillance.

READ MORE

Patient Engagement Group

The role of the patient in pharmacovigilance is key. The need for early involvement of the patient in the cycle of drug development is widely recognised, and direct patient reporting of ADRs is encouraged at many levels.

READ MORE
ISoP SIG
ISoP SIG

Ecopharmacovigilance

The environmental damage caused by the improper disposal and spillage of medicines is currently considered a major problem. However, there is no adequate measurement of the impact and scope of this problem on public health and the environment.

READ MORE

Drug Safety in Older Patients

At ISoP 2018 Annual Meeting in Geneva, a very successful pre-conference course on Drug Safety in Older Patients was organized. Some of the course speakers realized the topic was a neglected but very important field that required further development.

READ MORE
ISoP SIG